Eli Lilly | LLY - Interest Income

Stock Price
878.94
Daily Change
-5.02 -0.57%
Monthly
-0.87%
Yearly
0.19%
Q2 Forecast
865.04

Eli Lilly reported $65M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
AbbVie USD 72M 10M Sep/2025
Abbott USD 78M 1000K Dec/2025
ALKERMES USD 11.94M 853K Sep/2025
AstraZeneca USD 85M 17M Sep/2025
Baxter International USD 10M 4M Sep/2025
Biogen USD 31.6M 700K Sep/2025
Drreddys Laboratories INR 796M 332M Dec/2025
Eli Lilly USD 65M 25M Sep/2025
Gilead Sciences USD 95M 7M Dec/2025
GlaxoSmithKline GBP 26M 24M Sep/2025
Glaxosmithkline GBP 26M 24M Sep/2025
J&J USD 2.14 237M Mar/2026
Medtronic USD 114M 23M Jan/2025
Merck USD 96M 27M Sep/2025
Pfizer USD 0.62 156M Sep/2025
Phibro Animal Health USD 0.08 0.09 Dec/2024
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Sanofi EUR 33M 81M Dec/2025
Sanofi EUR 114M 38M Sep/2025
United Therapeutics USD 46.4M 4.9M Sep/2025
Zoetis USD 26M 7M Sep/2025